New breathing support could save tiny lungs
NCT ID NCT07377955
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two types of high-frequency ventilators for premature babies born before 32 weeks who have breathing problems. The new mode, HFOV-VG, aims to deliver more stable breaths to reduce lung injury. Researchers will see if it lowers the chance of severe chronic lung disease or death compared to standard high-frequency ventilation.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- High-frequency oscillatory ventilation with volume guarantee (HFOV-VG) device
- What this could lead to
- If successful, this could offer a safer breathing support method for premature infants, reducing severe lung disease and death.
- What could go wrong
- This trial hasn't started yet, and it's a single-center study. The new ventilator mode may not prove better than standard care, and results may not apply to all hospitals.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRONCHOPULMONARY DYSPLASIA (BPD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple blood test flag lung risk in preemies?
- Can a steroid shot into the windpipe protect preemies' lungs?
- Could a simple fat supplement protect preemie lungs?
- Vitamin a shown to protect tiny Preemies' lungs
- Which method helps premature babies breathe best? new study aims to find out.
- Cord blood transfusions could be safer for preterm babies